All News

Company moves away from manual processing in favour of automated, scalable platforms.

Company recognised for its innovation and continual delivery of new natural ingredients.

EU approves Novartis's Aimovig, a first-of-its-kind treatment specifically designed for migraine prevention.

Agreement includes Pall's next-generation Kaneka KanCapA 3G sorbent for the primary capture of mAbs from clarified cell culture.

The first non-radioactive, dual-tracer for sentinel lymph node biopsy approved in the US.

The plant will be first-of-its-kind in the US.

Supporting EM programs in preparation for proposed EU GMP Annex 1 changes.

One company's positive approach to Brexit preparations, despite the lack of definition.

I Holland to share their 70 years' experience in an ‘ultimate’ tooling seminar.

The EMA needs to provide more action and guidance to help UK pharmaceutical manufacturers, says Thomas Beck, senior vice president, quality management, Recipharm.

Dedicated facility developed in response to increasing demand for product development projects in diagnostics, R&D and bioprocess.

Pall and BioSciencesCorp unite to provide "total solutions" for today's drug manufacturers.

Risdrop, our innovative user-independent eye dropper, helps reduce the risk of overdosage by delivering the same drop every time irrespective of squeeze force and inclination.  

First CDMO in China that is approved to supply commercial APIs for innovative drugs by regulatory agencies in the US, China, EU, Canada, Switzerland, Australia, and New Zealand.

WuXi STA chosen for its end-to-end CMC platform for new drug development.

To meet new PV regulations, the industry has to face a "multitude of unknowns and an ever-moving target".

The AGF 5000 is a machine with a compact and space-saving design, easy handling and a small number of format parts.

The ability to micro size drug-cell interactions will allow pharmaceutical and biotech companies to do 100x more testing for the same money spent as well as increasing productivity.

Parallel cell line development and analysis will allow for optimal cell line selection while compressing the development timeline.

Action ensures that the US is prepared should smallpox be used as a bioweapon.

FDF launches at CPHI Korea as country set to become regional hub.

Company will offer compliant products to all markets, including Europe and the US.

Scientists see therapeutic potential against bacteria, viruses.

Dr Ramesh Jagadeesan, Sr. Director - Analytical Development at Recipharm, speaks to CPHI Online on the trends and challenges involved with conducting stability studies for firms that supply to multiple countries, and the advantages of using a contracto...

Winners will be announced live at the Gala Ceremony in Madrid with over 500 of Pharma’s top executives.

Company will be able to add 2D codes, human-readable text and tamper evidence to pre-packed medicines using existing equipment across its facilities.

Packaging technology is not a core Bosch business.

The latest developments in process development, nucleation control, scale-up of freeze drying cycles and development in lyophilization technology.

Consortium to develop advanced technologies for the manufacturing of ex vivo gene therapies.

Company's Wear Indicator Layer attracts the most attention.

Company consolidated as one of the leading laboratories in weight control thanks to the development of its existing range and new launches.

Peter Gough, NSF International’s Executive Director of Pharma Biotech, provided a practical overview of the regulatory implications of Brexit at the 2018 Pharmaceutical Industry Network Group (PING) seminar, held June 8, 2018 in Hertfordshire, UK.

The topical treatment for hair loss boasts a 'commercial' formulation.

Experts warn bio industry needs to do more to create a sustainable pipeline of talent.

Ruling prevents Dr Reddy's Laboratories will from launching their alternative salt forms of pemetrexed until the patent expires.

Approval for seizures associated with Lennox-Gastaut Syndrome or Dravet Syndrome, two rare, severe childhood-onset epilepsies.

Nottingham, UK – Juniper Pharma Services (JPS), a Contract Development and Manufacturing Organisation (CDMO) specialising in the development of challenging small molecules, has announced a significant expansion to its UK-based drug development and clin...

Ascendis Health is a South African-based international health care company marketing leading brands and products. Founded in 2008 and listed in the healthcare sector on the JSE in November 2013, the group has complemented its organic growth b...

MedPharm licenses its MedSpray ‘Patch-in-a-Can’ technology to Virpax Pharmaceuticals.

Next expansion step will increase finished product capacity for recombinant proteins by more than tenfold.

The Rocket 4D Synergy uses proprietary vacuum technology to suppress solvent bumping and foaming.

Breakthrough innovations in Freeze Drying Lyogistics Zero is the only vial automatic loading & unloading system for freeze-drying processes which can be cleaned (CIP) and sterilized (SIP) in place, inside the freeze-dryer chamber.

Researchers to benefit by receiving a rapid and cost-effective scaled supply of new compounds.

Acquired business will enhance Recipharm’s scale and provide access to new customers and higher margin specialised technologies.

Agreement will enable customers to achieve easier scalability of processes ranging from lab-scale to commercial-scale production of biopharmaceuticals.

The India Expo Mart brings the event closer to Indian regulatory and legislative hub and will encourage international audiences.

The Wear Indicator Layer is expected to have a "huge impact" on customers' production.

Company has developed a standard feature for its customers to execute the EMVO conformance testing successfully.

TAOS matrix system and products hailed as potential ‘game changers’ in the field of regenerative medicine.

Much needed more efficient manufacturing processes for ADCs aren't being completed by pharma.

‘Brexit taskforce’ will see Recipharm prioritise its preparations and invest in the necessary capabilities and equipment to ensure seamless operations post March 2019.

Forgotten markets of Africa and Arabia to see increased growth fuelled by international and domestic partnerships and imported APIs.

Company to streamline operations and capture cost synergies.

Testa Anayltical to discuss their latest developments and application advances in Light Scattering technology, GPC/SEC instrumentation and Zeta potential measurement.

New equipment allows Genvion to take customers from development through to commercial manufacture.

Tjoapack to perform the secondary packaging and assembly of product kits for supply to 25 European countries, the US, Canada and Australia.

New poster describes how the EAF4 module enabled simultaneous measurement of size and surface charge characteristics of antibodies and proteins.

Bosch's new Xelum R&D for continuous production of oral solid dosage forms ensures a short time-to-market and optimum dosing of APIs.

2018 event prepares for surge in international attendees as MAH nears national rollout.

Milan, Italy – Dipharma Francis S.r.l., (Dipharma), a leading European manufacturer of Active Pharmaceutical Ingredients, is pleased to communicate that it has completed its previously announced acquisition of Kalexsyn, Inc. (Kalexsyn), a world-...

Postponement printing is presenting interesting benefits for the pharmaceutical supply chain.

With the capacity expansion, Thermo Fisher will have the second largest base of single-use bioproduction capacity at a CDMO in the world.

Acquisition of AurKa Pharma expands Lilly's oncology pipeline with early-phase asset being studied in multiple tumour types.

Recipharm's Staffan Widengren, Director Corporate Projects, discusses why CMOs should be focusing on the value-added opportunities presented by serialisation.

In order to ensure a new manufacturing contract with Merck SA, Grupo Azevedos, an international pharmaceutical group, has invested 2M euros approx. in their own plant unit  Sofarimex with a new Groninger high-speed liquid filling line.
qq...

Allows for easy and intuitive scale-up from research.

Moehs group built a New Research Center,  A new state-of-the-art 2.762sqm facility. Full capacity and expert team for your projects.

Customers to gain a greater insight into their projects, better track project progress and improve communications.

Managing the risks associated with Industrial Hygiene and Quality and meeting operational efficiency targets.

New Industry 4.0 solutions from Bosch for more transparency.

Acquisition enables Ardena to manufacture batch sizes up to 100 kg.

Anmeal and Impax create diversified pharmaceutical company.

The integrated R&D and manufacturing facility is expecting more products to go into commercial production post approval.

NIAID-funded research could aid antimalarial drug development.

Noramco and SPI Pharma sign agreement to develop ready-to-implement, patient-friendly formulations for pharmaceutical manufacturers.

Integrated one-site solution for partners to push forward innovative APIs and advanced intermediates from preclinical to commercial stage.

Energy efficient, short cycle times and reliable product quality in large batches.

Retrofitting made easy

New Display and Operating Concept for the ALPINE Air Jet Sieve e200 LS

The latest air jet sieve in the family of ALPINE's air jet sieves e200 LS is the device for analysing the part...

Company to bring its new services and products into the spotlight at ACHEMA.

The CDMO's US sales have increased from £15.5 million to £41 million since 2016.

Sartorius Stedim Biotech introduces its mini microcarrier bioreactor for culturing adherent cells.

Dipharma Francis S.r.l. (Dipharma), a leading European manufacturer of Active Pharmaceutical Ingredients, and Kalexsyn, Inc. (Kalexsyn), a world-class Contract Research Organization (CRO) providing chemistry services to the biotechnology and pharmaceut...

Investment enhances the CDMO's scale-up and small to midscale commercial API manufacturing capabilities.

Grabs, Switzerland: – Top-loading parenteral and secondary packaging specialist Dividella has set a new benchmark for high speed parenteral packaging with its latest NeoTRAY fully automatic family of cartoners that supports outputs up to 40 million...

The contract manufacturer strengthens its pharmaceutical-protein business with Dutch acquisition

First customers have implemented portfolio changes.

MD-026 is the first RSK inhibitor to demonstrate potential disease-modifying properties in triple-negative breast cancer.

The UK’s most prestigious business award granted in recognition of outstanding achievement in the export of services for gene and immunotherapy products. Cobra Biologics ("Cobra")  today announced that it has been awarded the Queen’s ...

Sale of oncology business unlocks embedded value within Shire’s portfolio and sharpens focus on core areas reinforcing the company's leadership in rare diseases.

A new method of lyophilisation or freeze drying that uses a single, sterilisable, closed vessel to deliver lump free, fine powder product has the capability to revolutionise the production of bulk pharmaceutical powders. With the benefits of improve...

Posted February 22, 2018 in Announcements

Princeton, NJ – (February 22, 2018) Systech International, a global technology leader in brand protection, authentication, and product safety today announced enhanced functiona...

Posted January 12, 2018 in Announcements

Brussels, Belgium – (January 12, 2018) Systech International, the global technology leader in serialisation, track and trace, and brand protection grew its European presence in ...

Posted November 22, 2017 in Announcements

Princeton, NJ – (November 22, 2017) Systech International, a global technology leader in serialization, product safety, and consumer and brand protection, and NKP Pharma, ...

Posted October 9, 2017 in Announcements

Princeton, NJ – (October 9, 2017) Systech International, a global technology leader in product safety, and consumer and brand protection, and Toppan, a leading integrated pr...

Investment will focus on the rapid and successful development of processes to supply clinical and commercial demand for chemical syntheses.

Carbon footprint reduced by more than 70%.

Expansion meets the demand for additional capacity to serve large-scale clinical studies and provides the space for future growth.

NIH-funded study finds omega-3 fails to yield beneficial results in the clinic.

New Toronto facility is one of the largest-ever investments by Sanofi in a single building.

Purpose-built compliance solution for smaller pharmaceutical companies.

First-of-its-kind, state-of-the-art manufacturing facility with capacity to produce treatment for thousands of patients suffering from rare genetic disorders or life-threatening diseases.

SVP250 LF processing system minimizes product loss thanks to conical vessel shape.

Revolutionary, innovative plant offers greater flexibility, speed and efficiency.

The event will annually switch between Indonesia and Thailand to cater to attendees that were previously unable to participate.

The IHD series has been specially designed for coating and granulating pharmaceutical products with hot greases and waxes.

Pharma Liquid World shows the connection of a preparation system and filling machine, as well as robotic technology in aseptic filling.

With the new, intuitively operable control and evaluation software PAQXOS, Sympatec supports first time users as well as experts during particle characterisation. A newly developed, freely adaptable user interface, fully automated system detection, int...

The company’s environmental efforts honored for the fourth consecutive year.

With the acquisition of Irvine Scientific, FujiFilm will have a full product line supporting customers supplying antibody drugs to assisted reproductive technologies and cell therapy.

Servier CDMO is proud to announce we have been recognized across 11 categories in the 2018 CMO Leadership Awards, meeting or exceeding customer expectations in the core categories of Capabilities, Compatibility, Expertise, Quality, Reliability and Serv...

BioDuro announces creation of AISF ([4-(Acetylamino)phenyl]-ImidodiSulfuryl diFluoride), a convenient, shelf-stable, crystalline reagent for the synthesis of fluorosulfates and sulfamoyl fluorides, in a research collaboration with Pfizer.

The investment makes Idifarma one of only three companies in the world offering this type of contract development and manufacturing spray drying service.

Customers stand to benefit from broader services covering their API, drug product, regulatory CMC and bioanalysis requirements.

Expansion increases the facility’s manufacturing capacity by 200 million unidoses/year.

Customers to benefit from off-site training and solution testing without the downtime in the manufacturing and packaging processes.

Global analysis will rank each major biomanufacturing country’s market growth potential, innovation and competitiveness.

Extensive range of ready-to-use culture media available in bottles and plates.

Additional capacity expansion across several of the company's sites also strengthens the company's global market leadership in spray drying.

Bio and generic demand reflective of wider trends in the market – with overseas investments now prospering.

Unique, single-use perfusion system offers a fast-track to intensified cell culture process development.